Evaxion A/S (EVAX) Earnings Date & Reports

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVAX is expected to report earnings to fall 2,100.00% to 20 cents per share on August 20

Q2'26

Est.

$0.20

Q1'26

Missed

by $0.06

Q4'25

Missed

by $0.32

Q3'25

Beat

by $0.60

Q2'25

Missed

by $0.55

The last earnings report on May 07 showed earnings per share of 0 cents, missing the estimate of 5 cents. With 33.44K shares outstanding, the current market capitalization sits at 28.52M.

View a ticker or compare two or three

Compare

EVAX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for EVAX